Breast Cancer Clinical Trial
Effects of Physical Activity and Dietary Change in Minority Breast Cancer Survivors
Summary
This study is testing the effects of exercise and dietary change on weight reduction and biological markers associated with breast cancer risk in breast cancer survivors of Hispanic or African descent (n=45). This is a randomized, crossover pilot and feasibility study to test the effects of a 30-minute circuit-based exercise program that combines resistance training with aerobic exercise in conjunction with a low-fat calorie reduced diet. Participants will be randomized to either an immediate 6-months of exercise and dietary change, or a delayed group who will begin their exercise and dietary change program 6-months after the study begins. Participants in the immediate group will be followed for an additional 6-months in order to evaluate adherence to the exercise and dietary change recommendations. Participants in both groups will exercise at a neighborhood Curves® facility at least 5 times per week for six months and will participate in a series of nutrition education classes.
Eligibility Criteria
Inclusion Criteria:
21-70 yrs
Stage 0-IIIa breast cancer
No evidence of recurrent/metastatic disease
Hispanic or African descent (African-American or Caribbean)
BMI > 25kg/m2
Sedentary
Completed surgery, chemotherapy, and radiation therapy ≥ 6 months
Blood pressure < 140/90
HgbA1C < 8
LDL cholesterol < 150
No uncontrolled comorbidities
VO2 max normal EKG changes
Non-smoker
Exclusion Criteria:
Evidence of recurrent or metastatic breast cancer
Uncontrolled co-morbid illness including, but not limited to, type I diabetes mellitus, type II diabetes mellitus, hypertension, symptomatic congestive heart failure, unstable angina pectoris, claudication, cardiac arrhythmia; active pulmonary disease; hypercholesterolemia, neurological condition, ischemic heart disease, cardiac disease, kidney disease, respiration problems, asthma, shortness of breath, physical limitations, abnormal thyroid function, active malignancy, except for squamous or basal cell carcinoma of the skin; receiving active chemotherapy or radiotherapy; or psychiatric illness/social situations that would limit compliance with study requirements
Currently taking Herceptin therapy, or abnormal echo or MUGA post-Herceptin therapy
Active tobacco use
Currently active in an exercise and/or dietary change weight loss program
If a participant develops a breast cancer recurrence or metastasis during the 12-month study period, her participation in the study will be terminated.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
New York New York, 10032, United States
How clear is this clinincal trial information?

Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.